Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Causal Framework for Making Individualized Treatment Decisions in Oncology
Pavlos Msaouel, Juhee Lee, José A. Karam, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 3923-3923
Open Access | Times Cited: 22

Showing 22 citing articles:

Obesity and renal cell carcinoma: Biological mechanisms and perspectives
Neha Venkatesh, Alberto Martini, Jennifer L. McQuade, et al.
Seminars in Cancer Biology (2023) Vol. 94, pp. 21-33
Open Access | Times Cited: 18
Renal Cell Carcinoma of Variant Histology
Pavlos Msaouel, Giannicola Genovese, Nizar M. Tannir
Hematology/Oncology Clinics of North America (2023) Vol. 37, Iss. 5, pp. 977-992
Open Access | Times Cited: 17
Interpreting Randomized Controlled Trials
Pavlos Msaouel, Juhee Lee, Peter F. Thall
Cancers (2023) Vol. 15, Iss. 19, pp. 4674-4674
Open Access | Times Cited: 15
The Influence of Obesity on Outcomes with Immune Checkpoint Blockade: Clinical Evidence and Potential Biological Mechanisms
Andrew W. Hahn, Neha Venkatesh, Pavlos Msaouel, et al.
Cells (2023) Vol. 12, Iss. 21, pp. 2551-2551
Open Access | Times Cited: 11
Incomplete Toxicity Reporting and Use of Toxicity-Minimizing Language in Phase III Oncology Trials
Avital M. Miller, Adina H. Passy, Alexander D. Sherry, et al.
JCO Oncology Practice (2025)
Closed Access
Survival-Inferred Fragility of Statistical Significance in Phase III Oncology Trials
Alexander D. Sherry, Yufei Liu, Pavlos Msaouel, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Directed acyclic graphs as conceptual and analytical tools in applied and theoretical epidemiology: advances, setbacks and future possibilities
George T. H. Ellison, Hanan Rhoma
Mathematical Biosciences & Engineering (2025) Vol. 22, Iss. 6, pp. 1280-1306
Open Access
Perception, Cognition and Thought: Part I Nature, Evolution and Development of Conceptual and Symbolic Processes
Gary H. Lyman
Cancer Investigation (2023) Vol. 41, Iss. 6, pp. 535-538
Open Access | Times Cited: 10
Differential Treatment Effects of Subgroup Analyses in Phase 3 Oncology Trials From 2004 to 2020
Alexander D. Sherry, Andrew W. Hahn, Zachary R. McCaw, et al.
JAMA Network Open (2024) Vol. 7, Iss. 3, pp. e243379-e243379
Open Access | Times Cited: 3
Evidenced-Based Prior for Estimating the Treatment Effect of Phase III Randomized Trials in Oncology
Alexander D. Sherry, Pavlos Msaouel, Gabrielle S. Kupferman, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access | Times Cited: 3
Locoregional Therapies in Immunologically “Cold” Tumors: Opportunities and Clinical Trial Design Considerations
Pavlos Msaouel, Rahul A. Sheth
Journal of Vascular and Interventional Radiology (2024) Vol. 35, Iss. 2, pp. 198-202
Open Access | Times Cited: 2
Decoding Randomized Controlled Trials: An Information Science Perspective
Pavlos Msaouel
Harvard data science review (2024) Vol. 6, Iss. 2
Open Access | Times Cited: 2
Towards Treatment Effect Interpretability: A Bayesian Re-analysis of 194,129 Patient Outcomes Across 230 Oncology Trials
Alexander D. Sherry, Pavlos Msaouel, Gabrielle S. Kupferman, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 Fallacy
Alexander D. Sherry, Pavlos Msaouel, Zachary R. McCaw, et al.
European Journal of Cancer (2023) Vol. 194, pp. 113357-113357
Open Access | Times Cited: 6
The Role of Sampling in Medicine
Pavlos Msaouel
Harvard data science review (2023) Vol. 5, Iss. 3
Open Access | Times Cited: 5
An Evidenced-Based Prior for Estimating the Treatment Effect of Phase III Randomized Trials in Oncology
Alexander D. Sherry, Pavlos Msaouel, Gabrielle S. Kupferman, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Real‐world practitioner perceptions of CARTITUDE‐4 results for patients with previously treated multiple myeloma
Alexandrina Balanean, Samuel Baird, Brooke N. Dulka, et al.
eJHaem (2024) Vol. 5, Iss. 6, pp. 1154-1164
Open Access | Times Cited: 1
Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis of Individual Patient Data
Dimitrios Makrakis, Pavlos Msaouel, José A. Karam, et al.
European Urology Focus (2024)
Closed Access | Times Cited: 1
Less is More? First Impressions From COSMIC-313
Pavlos Msaouel
Cancer Investigation (2022) Vol. 41, Iss. 1, pp. 101-106
Closed Access | Times Cited: 7
Risk–benefit trade-offs and precision utilities in phase I-II clinical trials
Pavlos Msaouel, Juhee Lee, Peter F. Thall
Clinical Trials (2023) Vol. 21, Iss. 3, pp. 287-297
Open Access | Times Cited: 2
Pathways for non-manufacturers to drive generic drug repurposing for cancer in the U.S.
Devon Crittenden, R. Gallagher, Fernanda Milans del Bosch, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Interpreting Randomized Controlled Trials
Pavlos Msaouel, Juhee Lee, Peter F. Thall
(2023)
Open Access | Times Cited: 1
Gender disparity trends in genitourinary oncology academic publishing over the past 3 decades: A bibliometric analysis
Michaella Alexandrou, Tatiana S. Driva, Stavriani C. Makri, et al.
Urologic Oncology Seminars and Original Investigations (2023) Vol. 41, Iss. 10, pp. 432.e21-432.e27
Closed Access
Page 1

Scroll to top